What are the main functions and indications of Vigabatrin (vigabatrin)?

Vigabatrin (Vigabatrin) is an anti-epileptic drug with a special mechanism. It is mainly used to treat infantile spasms (West syndrome) and refractory partial epilepsy that are ineffective with other drugs. It inhibits γ-aminobutyric acid (GABA) degrading enzyme - GABAaminase, thereby increasing the concentration of GABA in the brain, inhibiting abnormal nerve discharges and stabilizing nerve activity, and is therefore widely used to control various types of epileptic seizures.

In terms of indications, Vigabatrin is mainly used to treat West syndrome that begins in infancy, a severe epilepsy syndrome that often manifests as nodding spasms and high-amplitude sharp waves on the electroencephalogram. Vigabatrin is one of the drugs of choice for this type of disease, especially for infantile spasms caused by tuberous sclerosis. In addition, Vigabatrin can also be used as an auxiliary treatment drug for adults or children with partial epilepsy who are ineffective when treated with other anti-epileptic drugs.

It is worth noting that although Vigabatrin is effective in controlling epileptic seizures, it should be used with caution. Since this drug may cause serious side effects such as visual field loss, a visual acuity evaluation is required before use and the visual field must be reviewed regularly during treatment. The doctor will evaluate the pros and cons based on the patient's condition to minimize the occurrence of adverse reactions while ensuring the curative effect.

In conclusion, vigabatrin, as an antiepileptic drug with a unique mechanism of action, provides an important treatment option for patients with infantile spasms and refractory epilepsy. However, during the medication process, it is necessary to strictly follow the doctor's instructions and pay attention to vision monitoring and adverse reaction management to ensure both safety and efficacy. For parents and patients, understanding the indications and risks of drugs can help achieve more standardized and effective treatment.

Reference materials:https://www.sabril.net/